Direct oral anticoagulant plasma levels and thrombin generation on ST Genesia system

Direct oral anticoagulant plasma levels and thrombin generation on ST Genesia system

Abstract Background Monitoring of anticoagulant activity of direct oral anticoagulants (DOACs) can be necessary in special situations. DOAC plasma levels have a high inter‐ and intraindividual variation and do not necessarily reflect the coagulation status of the patient. Thrombin generation (TG) is...

Cur síos iomlán

Sonraí bibleagrafaíochta
Príomhchruthaitheoirí:	Christian Pfrepper, Michael Metze, Annelie Siegemund, Tristan Klöter, Thomas Siegemund, Sirak Petros
Formáid:	Alt
Teanga:	English
Foilsithe / Cruthaithe:	Elsevier 2020-05-01
Sraith:	Research and Practice in Thrombosis and Haemostasis
Ábhair:	anti‐Xa‐inhibitors correlation dabigatran DOAC plasma levels ST Genesia thrombin generation
Rochtain ar líne:	https://doi.org/10.1002/rth2.12340

Míreanna comhchosúla

Inhibition of thrombin generation 12 hours after intake of direct oral anticoagulants
de réir: Michael Metze, et al.
Foilsithe / Cruthaithe: (2020-05-01)

Thrombin generation measured on ST Genesia, a new platform in the coagulation routine lab: Assessment of analytical and between‐subject variation
de réir: Søren Risom Kristensen, et al.
Foilsithe / Cruthaithe: (2022-01-01)

Calibrated automated thrombogram II: removing barriers for thrombin generation measurements
de réir: P. L. A. Giesen, et al.
Foilsithe / Cruthaithe: (2021-08-01)

Factor Xa and thrombin induce endothelial progenitor cell activation. The effect of direct oral anticoagulants
de réir: Styliani Papadaki, et al.
Foilsithe / Cruthaithe: (2021-08-01)

The novel anticoagulants: entering a new era
de réir: Swiss Medical Weekly
Foilsithe / Cruthaithe: (2009-02-01)

Semi-automated thrombin dynamics applying the ST Genesia thrombin generation assay
de réir: Audrey Carlo, et al.
Foilsithe / Cruthaithe: (2022-07-01)

Direct oral anticoagulant blood level monitoring in daily practice
de réir: R. Bavalia, et al.
Foilsithe / Cruthaithe: (2021-05-01)

Anticoagulated patients exhibit intact endogenous thrombin potential using ST Genesia unlike the Calibrated Automated Thrombogram
de réir: Tuukka A. Helin, et al.
Foilsithe / Cruthaithe: (2021-03-01)

Thrombocytopenia induced by dabigatran: two case reports
de réir: Hyun Goo Kang, et al.
Foilsithe / Cruthaithe: (2017-06-01)

Serial thrombin generation and exploration of alternative anticoagulants in critically ill COVID-19 patients: Observations from Maastricht Intensive Care COVID Cohort
de réir: Tom W. van de Berg, et al.
Foilsithe / Cruthaithe: (2022-10-01)

Thrombin-induced platelet aggregation −effect of dabigatran using automated platelet aggregometry−
de réir: Mie Shimizu, et al.
Foilsithe / Cruthaithe: (2020-04-01)

Practical issues in measuring the anticoagulant effect of direct oral anticoagulants
de réir: Dopsaj Violeta
Foilsithe / Cruthaithe: (2020-01-01)

Dabigatran Plasma Measurement to Guide the Management of Acute Bleeding and Thrombotic Complications
de réir: Maurizio Tala, et al.
Foilsithe / Cruthaithe: (2018-09-01)

Dabigatran Acylglucuronide, the Major Metabolite of Dabigatran, Shows a Weaker Anticoagulant Effect than Dabigatran
de réir: Jong-Min Kim, et al.
Foilsithe / Cruthaithe: (2022-01-01)

Direct oral anticoagulants in cirrhosis: Rationale and current evidenceKeypoints
de réir: Cindy Pereira Portela, et al.
Foilsithe / Cruthaithe: (2024-08-01)

Clinical characteristics of patients with direct oral anticoagulant (DOAC) levels outside expected ranges: A retrospective chart study
de réir: Dionne C.W. Braeken, et al.
Foilsithe / Cruthaithe: (2023-05-01)

Comparison of the pharmacokinetics and pharmacodynamics of apixaban and rivaroxaban in dogs
de réir: Alex M. Lynch, et al.
Foilsithe / Cruthaithe: (2024-11-01)

Direct oral anticoagulants; a review for the non-specialist
de réir: Thilina Gunawardena
Foilsithe / Cruthaithe: (2021-11-01)

Direct oral anticoagulant: Review article
de réir: Abdulrahman Nasiri, et al.
Foilsithe / Cruthaithe: (2022-01-01)

The new way of Dabigatran reversal – Idarucizumab
de réir: Erwin Ciechański, et al.
Foilsithe / Cruthaithe: (2019-02-01)

The new way of Dabigatran reversal – Idarucizumab
de réir: Erwin Ciechański, et al.
Foilsithe / Cruthaithe: (2019-02-01)

Hospital consumption of direct oral anticoagulants in regions of the Russian Federation in 2017–2022
de réir: A. V. Matveev, et al.
Foilsithe / Cruthaithe: (2024-01-01)

Effects of direct oral anticoagulants dabigatran and rivaroxaban on the blood coagulation function in rabbits
de réir: Yin Lu, et al.
Foilsithe / Cruthaithe: (2022-01-01)

Thrombin generation measurement using the ST Genesia Thrombin Generation System in a cohort of healthy adults: Normal values and variability
de réir: Sara Calzavarini, et al.
Foilsithe / Cruthaithe: (2019-10-01)

Distinct pleiotropic effects of direct oral anticoagulants on cultured endothelial cells: a comprehensive review
de réir: Natalia Atzemian, et al.
Foilsithe / Cruthaithe: (2023-09-01)

Dabigatran etexilate - A novel oral anticoagulant for bleeding complications
de réir: Himabindu Reddy, et al.
Foilsithe / Cruthaithe: (2015-09-01)

Effect of PCC on Thrombin Generation among Patients on Factor Xa Inhibitors with Major Bleeding or Needing Urgent Surgery (GAUGE): Design and Rationale
de réir: Shaw Shaw, et al.
Foilsithe / Cruthaithe: (2023-07-01)

Is There an Alternative Oral Anticoagulation to Vitamin-K-Antagonists for Patients with Mechanical Aortic Valve Replacement? – A Literature Review
de réir: Stephen Gerfer, et al.
Foilsithe / Cruthaithe: (2024-05-01)

Lupus anticoagulant testing during anticoagulation, including direct oral anticoagulants
de réir: Emmanuel J. Favaloro, et al.
Foilsithe / Cruthaithe: (2022-02-01)

Thrombin and factor Xa link the coagulation system with liver fibrosis
de réir: Ameet Dhar, et al.
Foilsithe / Cruthaithe: (2018-05-01)

An update on applications and limitations of direct oral anticoagulants
de réir: Sharon Wei, et al.
Foilsithe / Cruthaithe: (2023-04-01)

Analytical performance of the endogenous thrombin potential–based activated protein C resistance assay on the automated ST Genesia system
de réir: Laure Morimont, et al.
Foilsithe / Cruthaithe: (2022-03-01)

Direct Thrombin Inhibitor Dabigatran Compromises Pulmonary Endothelial Integrity in a Murine Model of Breast Cancer Metastasis to the Lungs; the Role of Platelets and Inflammation-Associated Haemostasis
de réir: Marta Smeda, et al.
Foilsithe / Cruthaithe: (2022-02-01)

Dabigatran mitigates cisplatin-mediated nephrotoxicity through down regulation of thrombin pathway
de réir: Mohamed Gamal El-Din Ewees, et al.
Foilsithe / Cruthaithe: (2021-07-01)

Reference values for thrombin dynamics in platelet rich plasma
de réir: Qiuting Yan, et al.
Foilsithe / Cruthaithe: (2021-02-01)

Evaluation of the Determination of Dabigatran, Rivaroxaban, and Apixaban in Lupus Anticoagulant-Positive Patients
de réir: Jana Úlehlová, et al.
Foilsithe / Cruthaithe: (2021-11-01)

Direct oral anticoagulants in pediatric venous thromboembolism: Review of approved products rivaroxaban and dabigatran
de réir: Maha Al-Ghafry, et al.
Foilsithe / Cruthaithe: (2022-10-01)

Dabigatran etexilate: a direct thrombin inhibitor
de réir: M. Dugnani
Foilsithe / Cruthaithe: (2013-05-01)

Safety of Dabigatran as an Anticoagulant: A Systematic Review and Meta-Analysis
de réir: Ya Zhou, et al.
Foilsithe / Cruthaithe: (2021-02-01)

Viscoelastometry for detecting oral anticoagulants
de réir: Philipp Groene, et al.
Foilsithe / Cruthaithe: (2021-03-01)